1.Kaper, JB, et al. Cholera. Journal of Clinical Microbiology Review 1995; 8: 48–86.
2.Faruque, SM, Albert, MJ, Mekalanos, JJ. Epidemiology, genetics and ecology of toxigenic Vibrio cholerae. Microbiology and Molecular Biology Reviews 1998; 62: 1301–1314.
3.Griffith, DC, et al. Review of reported cholera outbreaks worldwide, 1995–2005. American Journal of Tropical Medicine and Hygiene 2006; 75: 973–977.
4.Bompangue, D, et al. Lakes as source of cholera outbreaks, Democratic Republic of Congo. Emerging Infectious Diseases 2008; 14: 798–800.
5.Smith, AM, et al. Characterization of cholera outbreak isolates from Namibia, December 2006 to February 2007. Epidemiology and Infection 2007; 29: 1–3.
6.World Health Organization.Cholera annual report. Weekly Epidemiological Record 2009; 84: 309–329.
7.World Health Organization.Cholera in 2004. Weekly Epidemiological Record 2005; 80: 261–268.
8.Ansaruzzaman, M, et al. Cholera in Mozambique, variant of Vibrio cholerae. Emerging Infectious Diseases 2004; 10: 2057–2059.
9.Mwansa, JC, et al. Multiply antibiotic-resistant Vibrio cholerae O1 biotype El Tor strains emerges during cholera outbreaks in Zambia. Epidemiology and Infection 2006; 23: 1–7.
10.Finkelstein, R A, et al. Antigenic determinants of the cholera/coli family of enterotoxins. Review of Infectious Diseases 1987; 9: 490–502.
11.Morita, M, et al. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiology and Immunology 2008; 52: 314–317.
12.Olsvik, Ø, et al. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. Journal of Clinical Microbiology 1993; 31: 22–25.
13.Nair, GB, et al. New variants of Vibrio cholerae O1 biotype El Tor with attributes of the classical biotype from hospitalized patients with acute diarrhea in Bangladesh. Journal of Clinical Microbiology 2002; 40: 3296–3299.
14.Nusrin, S, et al. Diverse ctx phages among toxigenic Vibrio cholerae O1 and O139 strains isolated between 1994 and 2002 in an area where cholera is endemic in Bangladesh. Journal of Clinical Microbiology 2004; 42: 5854–5856.
15.Nair, GB, et al. Cholera due to altered El Tor strains of Vibrio cholerae O1 in Bangladesh. Journal of Clinical Microbiology 2006; 44: 4211–4213.
16.Raychoudhuri, A, et al. Classical ctxB in Vibrio cholerae O1, Kolkata, India. Emerging Infectious Diseases 2009; 15: 131–132.
17.Dziejman, M, et al. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proceedings of the National Academy of Sciences USA 2002; 99: 1556–1561.
18.Chowdhury, NR, et al. Molecular evidence of clonal Vibrio parahaemolyticus pandemic strains. Emerging Infectious Diseases 2000; 6: 631–636.
19.Morita, M, et al. Development and validation of a mismatch amplification mutation PCR assay to monitor the dissemination of an emerging variant of Vibrio cholerae O1 biotype El Tor. Microbiology and Immunology 2008; 52: 314–317.
20.Chow, KH, et al. Detection of RTX toxin gene in Vibrio cholerae by PCR. Journal of Clinical Microbiology 2001; 39: 2594–2597.
21.O'Shea, YA, et al. Evolutionary genetic analysis of the emergence of epidemic Vibrio cholerae isolates based on comparative nucleotide sequence analysis and multilocus virulence gene profiles. Journal of Clinical Microbiology 2004; 42: 4657–4671.
22.Rivera, IN, et al. Genotypes associated with virulence in environmental isolates of Vibrio cholerae. Applied Environmental Microbiology 2001; 67: 2421–2429.
23.Keasler, SP, Hall, RH. Detecting and biotyping V. cholerae O1 with multiplex polymerase chain reaction. Lancet 1993; 341, 1661.
24.Mitra, RK, et al. Molecular characterization of rough variants of Vibrio cholerae isolated from hospitalised patients with diarrhoea. Journal of Medical Microbiology 2001; 50: 268–276.
25.Altschul, SF, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 1997; 25: 3389–3402.
26.Cooper, KL, et al. Development and validation of a PulseNet standardized pulsed-field gel electrophoresis protocol for subtyping of Vibrio cholerae. Foodborne Pathogens and Disease 2006; 3: 51–58.
27.Nusrin, S, et al. Peruvian Vibrio cholerae O1 El Tor strains possess a distinct region in the Vibrio seventh pandemic island-II that differentiates them from the prototype seventh pandemic El Tor strains. Journal of Medical Microbiology 2009; 58: 342–254.
28.Taviani, E, et al. Discovery of novel Vibrio cholerae VSP-II genomic islands using comparative genomic analysis. 2010. FEMS Microbiology Letters 308: 130–137.
29.Herrington, DA, et al. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. Journal of Experimental Medicine 1988; 168: 1487–1492.
30.Kovach, ME, Shaffer, MD, Peterson, KM. A putative integrase gene defines the distal end of a large cluster of Tox-regulated colonization genes in Vibrio cholerae. Microbiology 1996; 142: 2165–2174.
31.DiRita, VJ, et al. Differential expression of ToxR regulon in classical and El Tor biotypes of Vibrio cholerae is due to biotype-specific control over ToxT expression. Proceedings of the National Academy of Sciences USA 1996; 93: 7991–7995.
32.Jonson, G, Holmgren, J, Svennerholm, AM. Identification of a mannose-binding pilus on Vibrio cholerae El Tor. Microbial Pathogenesis 1991; 11: 433–441.
33.Brown, MH, Manning, PA. Haemolysin genes of Vibrio cholerae: presence of homologous DNA in non-haemolytic O1 and haemolytic non-O1 strains. FEMS Microbiology Letters 1985; 30: 197–201.
34.Davis, BM, Waldor, MK. Filamentous phages linked tovirulence of Vibrio cholerae. Current Opinion in Microbiology 2003; 6: 35–42.
35.Brickman, TJ, et al. Molecular cloning and nucleotide sequence analysis of cholera toxin genes of the CtxA2 Vibrio cholerae strains Texas Star-SR. Infection and Immunity 1990; 58: 4142–4144.
36.Mekalanos, JJ, et al. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature 1993; 306: 551–557.